Armata Pharmaceuticals Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$7.70

-0.38 (-4.70%)

As of Feb 8, 2:00 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +126.6% upside

Low Target $10.78

Average Target $17.45

High Target $19.60

Current Price $7.70

Current
$7.70

Target
$17.45

$10.78 $17.45 avg $19.60

Scenario Analysis

Bear Case

$10.78

40.0%

Low target

Base Case

$17.45

+126.6%

Avg target

Bull Case

$19.60

+154.5%

High target

Risk/Reward

3.9x

Highly favorable

Price in Context

52-Week High

$14.09

-45.4% from high

52-Week Low

$6.73

+14.4% from low

Target vs 52W High

$17.45

+23.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%